Presentation is loading. Please wait.

Presentation is loading. Please wait.

From: Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver DiseaseA Systematic Review.

Similar presentations


Presentation on theme: "From: Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver DiseaseA Systematic Review."— Presentation transcript:

1 From: Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver DiseaseA Systematic Review Ann Intern Med. 2017;166(3): doi: /M Figure Legend: BNP = brain natriuretic peptide; CHF = congestive heart failure; CKD = chronic kidney disease; CT = computed tomography; CV = cardiovascular; DM = diabetes mellitus; DM2 = type 2 diabetes mellitus; eGFR = estimated glomerular filtration rate; FBS = fasting blood sugar; f/u = follow-up; HbA1c = hemoglobin A1c; HTN = hypertension; ICD = International Classification of Diseases; MACEs = major adverse cardiovascular events; MI = myocardial infarction; NA = not applicable; NR = not reported; PE = physical examination. Date of download: 11/4/2017 Copyright © American College of Physicians. All rights reserved.


Download ppt "From: Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver DiseaseA Systematic Review."

Similar presentations


Ads by Google